Intestinal Pseudo Obstruction Treatment Market Size, Share, Growth & Forecast 2027

Report Description

Global intestinal pseudo obstruction treatment market is expected to grow with an impressive CAGR in the forecast period, 2023-2027 due to growing healthcare industry. Increasing instances of complexities in the diseases and its after effects, further drive the growth of the global intestinal pseudo obstruction treatment market in the upcoming five years.

Intestinal pseudo obstruction is a rare condition where muscle impairment causes disruption in the gastro-intestinal muscle contraction. Thus, movement of the food gets obstructed and cause various abnormalities. The disease is of two types: abnormalities of the gastrointestinal muscles themselves (myogenic) or problems with the nerves that control the muscle contractions (neurogenic). There is no real obstruction but the lacks of the human muscles and neurons that fail to function appropriately. Due to the condition of intestinal pseudo obstruction, partially digested food in the intestines gets accumulated that further causes abdominal swelling, pain, nausea, vomiting, and constipation or diarrhea. Patients often lose appetite or have difficulty in nutrient absorption that may lead to malnutrition in extreme conditions.

Gastro Intestinal Conditions Drive Market Growth

Rapidly increasing instances of various stomach disorders, indigestion severity, and other related gastro intestinal diseases are anticipated to drive the growth of the global intestinal pseudo obstruction treatment market in the upcoming five years. Increasing geriatric population is also responsible for the market growth since the instances of the disorder in older and adult population is higher in comparison to children population. ‘

The condition in children is usually congenital. But the adult population develop the conditions due to neural degeneration or muscle abnormalities. In the year 2019, the United States 22% of the adult population were diagnosed with the intestinal pseudo obstruction conditions. Thus, the demand for the treatment of the condition rapidly grew in the past years, and it is anticipated to grow in future five years too. Moreover, in 2017, male adult population of the United States accounting for over 10% confirm that they suffer from excruciating pain due to gastro intestinal conditions and require intestinal pseudo obstruction treatment in a year.

Technological Advancement Supports Market Growth

Increasing advancement and consistent research toward improvising the technologies, products, and treatment methods for the intestinal pseudo obstruction treatment further substantiate the growth of the global intestinal pseudo obstruction treatment market in the next five years. Non-specific clinical symptoms, strong heterogeneity, and no definitive cause in some patients make diagnosis of the conditions very difficult. Gastro intestinal imaging and manometry of the organ tract is commonly used to diagnose the conditions of intestinal pseudo obstructions.

Click here to download the sample

Market Segmentation

The global intestinal pseudo obstruction treatment market segmentation is based on condition, diagnosis, treatment, end user, regional distribution, and competitive landscape. Based on condition, the market is divided between acute and chronic conditions. On the basis of diagnosis, the market is further bifurcated into blood test, gastric emptying tests, imaging tests, and others. Based on treatment, the market segment is defined into medication, surgery, diet, and others. The market analysis based on end user, is differentiated into hospitals & clinics, ambulatory care centers, others. The market analysis also studies the regional segmentation, divided among Asia-Pacific region, North American region, European region, South American region, and Middle East & African region.

Company Profile

Pfizer, Inc., Cipla Inc., GlaxoSmithKline Plc., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Novartis AG, Johnson & Johnson, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche AG, Lupin Limited, are enlisted in a partial list of major market players of the global intestinal pseudo obstruction treatment market.

Attribute	Details
Base Year	2021
Historical Data	2017 – 2020
Estimated Year	2022
Forecast Period	2023 – 2027
Quantitative Units	Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	· Condition · Diagnosis · Treatment · End User
Regional scope	North America; Europe; Asia Pacific; South America; Middle East & Africa
Country scope	United States, Mexico, Canada, China, India, Japan, South Korea, Australia, Germany, France, United Kingdom, Spain, Italy, South Africa, UAE, Saudi Arabia, Brazil, Argentina, Colombia.
Key companies profiled	Pfizer, Inc., Cipla Inc., GlaxoSmithKline Plc., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Novartis AG, Johnson & Johnson, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche AG, Lupin Limited
Customization scope	10% free report customization with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global intestinal pseudo obstruction treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Intestinal Pseudo Obstruction Treatment Market, By Condition:

Acute
Chronic

Intestinal Pseudo Obstruction Treatment Market, By Diagnosis:

Physical Examination
Biopsy
Blood Test
Gastric Emptying Tests
Imaging Tests
Others

Intestinal Pseudo Obstruction Treatment Market, By Treatment:

Medication
Surgery
Diet
Others

Intestinal Pseudo Obstruction Treatment Market, By End User:

Hospitals & Clinics
Ambulatory Care Centers
Others

Intestinal Pseudo Obstruction Treatment Market, By Region:

North America

United States
Mexico
Canada

Europe

France
Germany
United Kingdom
Italy
Spain

Asia-Pacific

China
India
Japan
South Korea
Australia

Middle East & Africa

South Africa
Saudi Arabia
UAE

South America

Brazil
Argentina
Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global intestinal pseudo obstruction treatment market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Intestinal pseudo obstruction treatment Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Intestinal Pseudo Obstruction Treatment Market

4. Executive Summary

5. Voice of Customer

5.1. Factors Contributing to Intestinal Pseudo Obstruction

5.2. Commonly Observed Symptoms of Intestinal Pseudo Obstruction

5.3. Intestinal Pseudo Obstruction Prevalence, By Age Group

5.4. Intestinal Pseudo Obstruction Prevalence, By Gender

5.5. Commonly Used Diagnostic Procedures for Intestinal Pseudo Obstruction

5.6. Preference for Intestinal Pseudo Obstruction Treatment, By Type

5.7. Brand Awareness

6. Global Intestinal Pseudo Obstruction Treatment Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Condition (Acute v/s Chronic)

6.2.2. By Diagnosis (Physical Examination, Biopsy, Blood Test, Gastric Emptying Tests, Imaging Tests, Others)

6.2.3. By Treatment (Medication, Surgery, Diet, Others)

6.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)

6.2.5. By Company (2021)

6.2.6. By Region

6.3. Product Market Map

7. North America Intestinal Pseudo Obstruction Treatment Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Condition

7.2.2. By Diagnosis

7.2.3. By Treatment

7.2.4. By End User

7.2.5. By Country

7.3. North America: Country Analysis

7.3.1. United States Intestinal Pseudo Obstruction Treatment Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Condition

7.3.1.2.2. By Diagnosis

7.3.1.2.3. By Treatment

7.3.1.2.4. By End User

7.3.2. Mexico Intestinal Pseudo Obstruction Treatment Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Condition

7.3.2.2.2. By Diagnosis

7.3.2.2.3. By Treatment

7.3.2.2.4. By End User

7.3.3. Canada Intestinal Pseudo Obstruction Treatment Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Condition

7.3.3.2.2. By Diagnosis

7.3.3.2.3. By Treatment

7.3.3.2.4. By End User

8. Europe Intestinal Pseudo Obstruction Treatment Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Condition

8.2.2. By Diagnosis

8.2.3. By Treatment

8.2.4. By End User

8.2.5. By Country

8.3. Europe: Country Analysis

8.3.1. France Intestinal Pseudo Obstruction Treatment Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Condition

8.3.1.2.2. By Diagnosis

8.3.1.2.3. By Treatment

8.3.1.2.4. By End User

8.3.2. Germany Intestinal Pseudo Obstruction Treatment Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Condition

8.3.2.2.2. By Diagnosis

8.3.2.2.3. By Treatment

8.3.2.2.4. By End User

8.3.3. United Kingdom Intestinal Pseudo Obstruction Treatment Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Condition

8.3.3.2.2. By Diagnosis

8.3.3.2.3. By Treatment

8.3.3.2.4. By End User

8.3.4. Italy Intestinal Pseudo Obstruction Treatment Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Condition

8.3.4.2.2. By Diagnosis

8.3.4.2.3. By Treatment

8.3.4.2.4. By End User

8.3.5. Spain Intestinal Pseudo Obstruction Treatment Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Condition

8.3.5.2.2. By Diagnosis

8.3.5.2.3. By Treatment

8.3.5.2.4. By End User

9. Asia-Pacific Intestinal Pseudo Obstruction Treatment Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Condition

9.2.2. By Diagnosis

9.2.3. By Treatment

9.2.4. By End User

9.2.5. By Country

9.3. Asia-Pacific: Country Analysis

9.3.1. China Intestinal Pseudo Obstruction Treatment Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Condition

9.3.1.2.2. By Diagnosis

9.3.1.2.3. By Treatment

9.3.1.2.4. By End User

9.3.2. India Intestinal Pseudo Obstruction Treatment Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Condition

9.3.2.2.2. By Diagnosis

9.3.2.2.3. By Treatment

9.3.2.2.4. By End User

9.3.3. South Korea Intestinal Pseudo Obstruction Treatment Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Condition

9.3.3.2.2. By Diagnosis

9.3.3.2.3. By Treatment

9.3.3.2.4. By End User

9.3.4. Japan Intestinal Pseudo Obstruction Treatment Market Outlook

9.3.4.1. Market Size & Forecast

9.3.4.1.1. By Value

9.3.4.2. Market Share & Forecast

9.3.4.2.1. By Condition

9.3.4.2.2. By Diagnosis

9.3.4.2.3. By Treatment

9.3.4.2.4. By End User

9.3.5. Australia Intestinal Pseudo Obstruction Treatment Market Outlook

9.3.5.1. Market Size & Forecast

9.3.5.1.1. By Value

9.3.5.2. Market Share & Forecast

9.3.5.2.1. By Condition

9.3.5.2.2. By Diagnosis

9.3.5.2.3. By Treatment

9.3.5.2.4. By End User

10. South America Intestinal Pseudo Obstruction Treatment Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Condition

10.2.2. By Diagnosis

10.2.3. By Treatment

10.2.4. By End User

10.2.5. By Country

10.3. South America: Country Analysis

10.3.1. Brazil Intestinal Pseudo Obstruction Treatment Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Condition

10.3.1.2.2. By Diagnosis

10.3.1.2.3. By Treatment

10.3.1.2.4. By End User

10.3.2. Argentina Intestinal Pseudo Obstruction Treatment Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Condition

10.3.2.2.2. By Diagnosis

10.3.2.2.3. By Treatment

10.3.2.2.4. By End User

10.3.3. Colombia Intestinal Pseudo Obstruction Treatment Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Condition

10.3.3.2.2. By Diagnosis

10.3.3.2.3. By Treatment

10.3.3.2.4. By End User

11. Middle East and Africa Intestinal Pseudo Obstruction Treatment Market Outlook

11.1. Market Size & Forecast

11.1.1. By Value

11.2. Market Share & Forecast

11.2.1. By Condition

11.2.2. By Diagnosis

11.2.3. By Treatment

11.2.4. By End User

11.2.5. By Country

11.3. MEA: Country Analysis

11.3.1. South Africa Intestinal Pseudo Obstruction Treatment Market Outlook

11.3.1.1. Market Size & Forecast

11.3.1.1.1. By Value

11.3.1.2. Market Share & Forecast

11.3.1.2.1. By Condition

11.3.1.2.2. By Diagnosis

11.3.1.2.3. By Treatment

11.3.1.2.4. By End User

11.3.2. Saudi Arabia Intestinal Pseudo Obstruction Treatment Market Outlook

11.3.2.1. Market Size & Forecast

11.3.2.1.1. By Value

11.3.2.2. Market Share & Forecast

11.3.2.2.1. By Condition

11.3.2.2.2. By Diagnosis

11.3.2.2.3. By Treatment

11.3.2.2.4. By End User

11.3.3. UAE Intestinal Pseudo Obstruction Treatment Market Outlook

11.3.3.1. Market Size & Forecast

11.3.3.1.1. By Value

11.3.3.2. Market Share & Forecast

11.3.3.2.1. By Condition

11.3.3.2.2. By Diagnosis

11.3.3.2.3. By Treatment

11.3.3.2.4. By End User

12. Market Dynamics

12.1. Drivers

12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

14.1. Pfizer, Inc.

14.2. Cipla Inc.

14.3. GlaxoSmithKline Plc.

14.4. Teva Pharmaceutical Industries Ltd.

14.5. Eli Lilly and Company

14.6. Novartis AG

14.7. Johnson & Johnson

14.8. Dr. Reddy’s Laboratories Ltd.

14.9. F. Hoffmann-La Roche AG

14.10. Lupin Limited

15. Strategic Recommendations

Figures and Tables

Frequently asked questions

What major factors drive Global Intestinal Pseudo Obstruction Treatment Market growth?

Surge in instances of gastro intestinal disorders are actively driving the growth of the global intestinal pseudo obstruction treatment market in the upcoming five years.

Which region dominates the Global Intestinal Pseudo Obstruction Treatment Market analysis?

The global intestinal pseudo obstruction treatment market is segmented into North America region, South America region, Asia Pacific region, European region, and Middle East & Africa region for the regional analysis of the market. North America region is anticipated to dominate the market analysis in the upcoming five years on the account of advancing healthcare industry and increasing investment in the healthcare sector in recent years.

Which companies dominate the Global Intestinal Pseudo Obstruction Treatment Market?

Pfizer, Inc., Cipla Inc., GlaxoSmithKline Plc., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, among others are some of the leading companies dedicated toward providing related products and services of intestinal pseudo obstruction treatment and support the future growth of the global intestinal pseudo obstruction treatment market in the upcoming five years.

What is the study period for the Global Intestinal Pseudo Obstruction Treatment Market analysis?

The global intestinal pseudo obstruction treatment market analysis was analyzed for the five historical years from 2017 to 2020. Keeping the base year 2020 as the margin, the estimation for the year 2022 was made and further market growth is predicted for the forecast years, 2023 to 2027.

Buy Now